12 U.S. lawmakers have disclosed 37 Express Scripts Holding Company trades under the STOCK Act — 18 buys and 18 sells between 2013 and 2018. Congress has been evenly split of ESRX.
*Notional-weighted price return on lawmakers' disclosed buys of ESRX, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2018-12-21 | Keith J. Rothfus | exchange | $1K–$15K | $92.33 | $92.33 2018-12-21 | 0.0% |
| 2018-10-05 | Gary Palmer | SELL | $1K–$15K | $96.03 | $92.33 2018-12-21 | +3.9% exit |
| 2018-10-03 | Lois Frankel | SELL | $1K–$15K | $95.34 | $92.33 2018-12-21 | +18.7% rt |
| 2018-05-04 | James B. Renacci | BUY | $1K–$15K | $70.22 | $92.33 2018-12-21 | +31.5% |
| 2018-01-10 | Lois Frankel | BUY | $1K–$15K | $80.35 | $92.33 2018-12-21 | +14.9% |
| 2017-09-14 | David B. McKinley | BUY | $1K–$15K | $62.34 | $92.33 2018-12-21 | +48.1% |
| 2017-03-15 | John F Reed | SELL | $1K–$15K | $66.06 | $92.33 2018-12-21 | -39.8% exit |
| 2017-03-06 | John F Reed | SELL | $1K–$15K | $70.05 | $92.33 2018-12-21 | -19.4% rt |
| 2016-12-21 | David B. McKinley | SELL | $15K–$50K | $68.50 | $92.33 2018-12-21 | -12.5% rt |
| 2016-12-20 | James B. Renacci | BUY | $1K–$15K | $68.65 | $92.33 2018-12-21 | +34.5% |
| 2016-12-16 | Susan M Collins | SELL | $1K–$15K | $69.92 | $92.33 2018-12-21 | +4.3% rt |
| 2016-12-16 | Susan M Collins | SELL | $1K–$15K | $69.92 | $92.33 2018-12-21 | -32.0% exit |
| 2016-10-13 | Richard L. Hanna | SELL | $15K–$50K | $69.04 | $92.33 2018-12-21 | -33.7% exit |
| 2016-08-08 | James M Inhofe | SELL | $50K–$100K | $75.91 | $92.33 2018-12-21 | -21.6% exit |
| 2016-07-07 | Sheldon Whitehouse | SELL | $15K–$50K | $76.55 | $92.33 2018-12-21 | +5.9% rt |
| 2016-07-07 | Sheldon Whitehouse | SELL | $1K–$15K | $76.55 | $92.33 2018-12-21 | +5.9% rt |
| 2016-04-26 | James B. Renacci | BUY | $1K–$15K | $74.26 | $92.33 2018-12-21 | +24.3% |
| 2016-03-04 | James B. Renacci | BUY | $1K–$15K | $71.69 | $92.33 2018-12-21 | +28.8% |
| 2015-12-17 | James B. Renacci | BUY | $1K–$15K | $86.65 | $92.33 2018-12-21 | +6.6% |
| 2015-10-16 | K. Michael Conaway | BUY | $1K–$15K | $86.22 | $92.33 2018-12-21 | +7.1% |
| 2015-09-18 | David B. McKinley | BUY | $15K–$50K | $83.92 | $92.33 2018-12-21 | +10.0% |
| 2015-04-23 | John F Reed | BUY | $1K–$15K | $86.89 | $92.33 2018-12-21 | +6.3% |
| 2015-04-15 | Lois Frankel | SELL | $1K–$15K | $87.06 | $92.33 2018-12-21 | -6.0% exit |
| 2015-04-08 | Lois Frankel | SELL | $1K–$15K | $84.36 | $92.33 2018-12-21 | -9.4% exit |
| 2015-03-11 | Lois Frankel | SELL | $1K–$15K | $81.24 | $92.33 2018-12-21 | -13.7% exit |
| 2015-01-30 | James B. Renacci | BUY | $1K–$15K | $80.71 | $92.33 2018-12-21 | +14.4% |
| 2015-01-05 | James B. Renacci | BUY | $1K–$15K | $84.22 | $92.33 2018-12-21 | +9.6% |
| 2014-07-18 | Alan S. Lowenthal | SELL | $1K–$15K | $66.00 | $92.33 2018-12-21 | -39.9% exit |
| 2014-07-17 | Alan S. Lowenthal | SELL | $15K–$50K | $65.60 | $92.33 2018-12-21 | -40.8% exit |
| 2014-05-07 | Susan M Collins | BUY | $1K–$15K | $67.05 | $92.33 2018-12-21 | +37.7% |
| 2014-04-29 | Sheldon Whitehouse | BUY | $1K–$15K | $71.01 | $92.33 2018-12-21 | +30.0% |
| 2014-04-29 | Sheldon Whitehouse | BUY | $1K–$15K | $71.01 | $92.33 2018-12-21 | +30.0% |
| 2014-04-17 | Sheldon Whitehouse | BUY | $1K–$15K | $72.29 | $92.33 2018-12-21 | +27.7% |
| 2014-04-17 | Sheldon Whitehouse | BUY | $1K–$15K | $72.29 | $92.33 2018-12-21 | +27.7% |
| 2014-03-07 | David B. McKinley | BUY | $1K–$15K | $78.30 | $92.33 2018-12-21 | +17.9% |
| 2014-02-26 | Susan M Collins | SELL | $1K–$15K | $74.00 | $92.33 2018-12-21 | -24.8% exit |
| 2013-10-25 | SUSAN M COLLINS | SELL | $1K–$15K | $60.88 | $92.33 2018-12-21 | -51.7% exit |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
12 members of the U.S. House and Senate have disclosed Express Scripts Holding Company transactions under the STOCK Act — 18 purchases and 18 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a ESRX purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Every ESRX trade is marked to the latest close in the Return column; sells matched to a prior buy show a realized round-trip return.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ESRX and how it performed.